CVS Health Corporation $CVS Stock Holdings Boosted by Krilogy Financial LLC

Krilogy Financial LLC increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 49.6% in the third quarter, Holdings Channel.com reports. The firm owned 19,343 shares of the pharmacy operator’s stock after buying an additional 6,411 shares during the quarter. Krilogy Financial LLC’s holdings in CVS Health were worth $1,658,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Kilter Group LLC acquired a new stake in CVS Health in the second quarter valued at approximately $27,000. Beaird Harris Wealth Management LLC increased its holdings in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 195 shares in the last quarter. J.Safra Asset Management Corp bought a new position in shares of CVS Health in the 2nd quarter valued at $30,000. Timbuktu Capital Management LLC bought a new position in shares of CVS Health in the 2nd quarter valued at $31,000. Finally, Dunhill Financial LLC bought a new position in shares of CVS Health in the 2nd quarter valued at $32,000. Institutional investors own 80.66% of the company’s stock.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Improving fundamentals and valuation support the stock. CVS has recently exceeded earnings and revenue expectations, while analysts cited stronger returns, rising earnings estimates and a lower valuation than Alignment Healthcare. Its Aetna turnaround is also viewed as a potential catalyst. CVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?
• Positive Sentiment: Expanded care access and quality credentials reinforce CVS’s healthcare-services strategy. CVS opened its first pharmacy-focused location in the Boston area to improve access to medications, immunizations and other services. Separately, MinuteClinic received its seventh consecutive Joint Commission accreditation, with primary care available at more than 65% of its locations. CVS Pharmacy Celebrates Opening of First Pharmacy-Focused Location in Boston Area
• Neutral Sentiment: New women’s-health collaboration could support longer-term engagement. CVS is partnering with The Midlife Collective on a research study and documentary focused on women’s midlife health. The initiative may strengthen brand awareness and consumer relationships, but it is unlikely to have a near-term financial impact. CVS Health Collaborates With The Midlife Collective
• Positive Sentiment: Home-based heart monitoring expands value-added services. Signify Health, part of CVS, offers continuous heart-rhythm monitoring for eligible health-plan members, potentially enabling earlier detection of serious conditions and supporting preventive-care economics. CVS Health: Early Detection Matters
• Negative Sentiment: $315 million opioid settlement creates legal, financial and reputational pressure. CVS agreed to settle Justice Department allegations involving unlawful opioid dispensing and false claims. The company admitted no wrongdoing but will implement tighter controlled-substance oversight, adding costs and highlighting compliance risks. CVS Agrees to Pay $315M

CVS Health Trading Up 2.3%

NYSE CVS opened at $92.45 on Friday. The business’s 50-day moving average price is $91.80 and its two-hundred day moving average price is $93.03. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The firm has a market capitalization of $118.25 billion, a PE ratio of 24.46, a price-to-earnings-growth ratio of 0.84 and a beta of 0.60. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The company had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter in the prior year, the firm posted $1.81 earnings per share. The business’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts expect that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be issued a dividend of $0.6650 per share. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 2.9%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on CVS shares. Weiss Ratings lowered CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 9th. Piper Sandler set a $112.00 target price on CVS Health in a report on Wednesday, September 9th. Royal Bank Of Canada increased their target price on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. HSBC reiterated a “hold” rating and issued a $103.00 target price on shares of CVS Health in a research report on Monday, July 6th. Finally, Leerink Partners cut their price target on CVS Health from $119.00 to $112.00 and set an “outperform” rating on the stock in a research note on Monday. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $107.80.

CVS Health Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.